United States Graft Versus Host Disease GvHD Treatment Market Report 2017

January 2017 | 122 pages | ID: UDB009B2590EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Graft Versus Host Disease GvHD Treatment

Revenue, means the sales value of Graft Versus Host Disease GvHD Treatment

This report studies sales (consumption) of Graft Versus Host Disease GvHD Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi
• Novartis AG
• Neovii Biotech GmbH
• Merck & Co
• Astellas Pharma
• Soligenix
• Mesoblast Ltd

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Monoclonal Antibodies
• MTOR Inhibitors
• Tyrosine Kinase Inhibitors
• Thalidomide
• Etanercept

Split by applications, this report focuses on sales, market share and growth rate of Graft Versus Host Disease GvHD Treatment in each application, can be divided into

• Hospitals
• Hospital Pharmacies
• Drug Stores
• Online Drug Stores

Contents

United States Graft Versus Host Disease GvHD Treatment Market Report 2017

1 GRAFT VERSUS HOST DISEASE GVHD TREATMENT OVERVIEW

1.1 Product Overview and Scope of Graft Versus Host Disease GvHD Treatment
1.2 Classification of Graft Versus Host Disease GvHD Treatment
  1.2.1 Monoclonal Antibodies
  1.2.2 MTOR Inhibitors
  1.2.3 Tyrosine Kinase Inhibitors
  1.2.4 Thalidomide
  1.2.5 Etanercept
1.3 Application of Graft Versus Host Disease GvHD Treatment
  1.3.1 Hospitals
  1.3.2 Hospital Pharmacies
  1.3.3 Drug Stores
  1.3.4 Online Drug Stores
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Graft Versus Host Disease GvHD Treatment (2012-2022)
  1.4.1 United States Graft Versus Host Disease GvHD Treatment Sales and Growth Rate (2012-2022)
  1.4.2 United States Graft Versus Host Disease GvHD Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT COMPETITION BY MANUFACTURERS

2.1 United States Graft Versus Host Disease GvHD Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Graft Versus Host Disease GvHD Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Graft Versus Host Disease GvHD Treatment Average Price by Manufactures (2015 and 2016)
2.4 Graft Versus Host Disease GvHD Treatment Market Competitive Situation and Trends
  2.4.1 Graft Versus Host Disease GvHD Treatment Market Concentration Rate
  2.4.2 Graft Versus Host Disease GvHD Treatment Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Graft Versus Host Disease GvHD Treatment Sales and Market Share by States (2012-2017)
3.2 United States Graft Versus Host Disease GvHD Treatment Revenue and Market Share by States (2012-2017)
3.3 United States Graft Versus Host Disease GvHD Treatment Price by States (2012-2017)

4 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Graft Versus Host Disease GvHD Treatment Sales and Market Share by Type (2012-2017)
4.2 United States Graft Versus Host Disease GvHD Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Graft Versus Host Disease GvHD Treatment Price by Type (2012-2017)
4.4 United States Graft Versus Host Disease GvHD Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Graft Versus Host Disease GvHD Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Graft Versus Host Disease GvHD Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT MANUFACTURERS PROFILES/ANALYSIS

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.1.2.1 Monoclonal Antibodies
    6.1.2.2 MTOR Inhibitors
  6.1.3 Sanofi Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.2.2.1 Monoclonal Antibodies
    6.2.2.2 MTOR Inhibitors
  6.2.3 Novartis AG Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Neovii Biotech GmbH
  6.3.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.3.2.1 Monoclonal Antibodies
    6.3.2.2 MTOR Inhibitors
  6.3.3 Neovii Biotech GmbH Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co
  6.4.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.4.2.1 Monoclonal Antibodies
    6.4.2.2 MTOR Inhibitors
  6.4.3 Merck & Co Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Astellas Pharma
  6.5.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.5.2.1 Monoclonal Antibodies
    6.5.2.2 MTOR Inhibitors
  6.5.3 Astellas Pharma Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Soligenix
  6.6.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.6.2.1 Monoclonal Antibodies
    6.6.2.2 MTOR Inhibitors
  6.6.3 Soligenix Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Mesoblast Ltd
  6.7.2 Graft Versus Host Disease GvHD Treatment Product Type, Application and Specification
    6.7.2.1 Monoclonal Antibodies
    6.7.2.2 MTOR Inhibitors
  6.7.3 Mesoblast Ltd Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 GRAFT VERSUS HOST DISEASE GVHD TREATMENT MANUFACTURING COST ANALYSIS

7.1 Graft Versus Host Disease GvHD Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Graft Versus Host Disease GvHD Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Graft Versus Host Disease GvHD Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Graft Versus Host Disease GvHD Treatment Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GRAFT VERSUS HOST DISEASE GVHD TREATMENT MARKET FORECAST (2017-2022)

11.1 United States Graft Versus Host Disease GvHD Treatment Sales, Revenue Forecast (2017-2022)
11.2 United States Graft Versus Host Disease GvHD Treatment Sales Forecast by Type (2017-2022)
11.3 United States Graft Versus Host Disease GvHD Treatment Sales Forecast by Application (2017-2022)
11.4 Graft Versus Host Disease GvHD Treatment Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Graft Versus Host Disease GvHD Treatment
Table Classification of Graft Versus Host Disease GvHD Treatment
Figure United States Sales Market Share of Graft Versus Host Disease GvHD Treatment by Type in 2015
Figure Monoclonal Antibodies Picture
Figure MTOR Inhibitors Picture
Figure Tyrosine Kinase Inhibitors Picture
Figure Thalidomide Picture
Figure Etanercept Picture
Table Application of Graft Versus Host Disease GvHD Treatment
Figure United States Sales Market Share of Graft Versus Host Disease GvHD Treatment by Application in 2015
Figure Hospitals Examples
Figure Hospital Pharmacies Examples
Figure Drug Stores Examples
Figure Online Drug Stores Examples
Figure United States Graft Versus Host Disease GvHD Treatment Sales and Growth Rate (2012-2022)
Figure United States Graft Versus Host Disease GvHD Treatment Revenue and Growth Rate (2012-2022)
Table United States Graft Versus Host Disease GvHD Treatment Sales of Key Manufacturers (2015 and 2016)
Table United States Graft Versus Host Disease GvHD Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Graft Versus Host Disease GvHD Treatment Sales Share by Manufacturers
Figure 2016 Graft Versus Host Disease GvHD Treatment Sales Share by Manufacturers
Table United States Graft Versus Host Disease GvHD Treatment Revenue by Manufacturers (2015 and 2016)
Table United States Graft Versus Host Disease GvHD Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Graft Versus Host Disease GvHD Treatment Revenue Share by Manufacturers
Table 2016 United States Graft Versus Host Disease GvHD Treatment Revenue Share by Manufacturers
Table United States Market Graft Versus Host Disease GvHD Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Graft Versus Host Disease GvHD Treatment Average Price of Key Manufacturers in 2015
Figure Graft Versus Host Disease GvHD Treatment Market Share of Top 3 Manufacturers
Figure Graft Versus Host Disease GvHD Treatment Market Share of Top 5 Manufacturers
Table United States Graft Versus Host Disease GvHD Treatment Sales by States (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Sales Share by States (2012-2017)
Figure United States Graft Versus Host Disease GvHD Treatment Sales Market Share by States in 2015
Table United States Graft Versus Host Disease GvHD Treatment Revenue and Market Share by States (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Revenue Share by States (2012-2017)
Figure Revenue Market Share of Graft Versus Host Disease GvHD Treatment by States (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Price by States (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Sales by Type (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Sales Share by Type (2012-2017)
Figure United States Graft Versus Host Disease GvHD Treatment Sales Market Share by Type in 2015
Table United States Graft Versus Host Disease GvHD Treatment Revenue and Market Share by Type (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Graft Versus Host Disease GvHD Treatment by Type (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Price by Type (2012-2017)
Figure United States Graft Versus Host Disease GvHD Treatment Sales Growth Rate by Type (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Sales by Application (2012-2017)
Table United States Graft Versus Host Disease GvHD Treatment Sales Market Share by Application (2012-2017)
Figure United States Graft Versus Host Disease GvHD Treatment Sales Market Share by Application in 2015
Table United States Graft Versus Host Disease GvHD Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Graft Versus Host Disease GvHD Treatment Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Neovii Biotech GmbH Basic Information List
Table Neovii Biotech GmbH Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Neovii Biotech GmbH Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Soligenix Basic Information List
Table Soligenix Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Soligenix Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Mesoblast Ltd Basic Information List
Table Mesoblast Ltd Graft Versus Host Disease GvHD Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mesoblast Ltd Graft Versus Host Disease GvHD Treatment Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Graft Versus Host Disease GvHD Treatment
Figure Manufacturing Process Analysis of Graft Versus Host Disease GvHD Treatment
Figure Graft Versus Host Disease GvHD Treatment Industrial Chain Analysis
Table Raw Materials Sources of Graft Versus Host Disease GvHD Treatment Major Manufacturers in 2015
Table Major Buyers of Graft Versus Host Disease GvHD Treatment
Table Distributors/Traders List
Figure United States Graft Versus Host Disease GvHD Treatment Production and Growth Rate Forecast (2017-2022)
Figure United States Graft Versus Host Disease GvHD Treatment Revenue and Growth Rate Forecast (2017-2022)
Table United States Graft Versus Host Disease GvHD Treatment Production Forecast by Type (2017-2022)
Table United States Graft Versus Host Disease GvHD Treatment Consumption Forecast by Application (2017-2022)
Table United States Graft Versus Host Disease GvHD Treatment Sales Forecast by States (2017-2022)
Table United States Graft Versus Host Disease GvHD Treatment Sales Share Forecast by States (2017-2022)